News, reviews and podcasts from annual scientific meetings and symposiums around the world.
Results from the OPTIMISMM study, a phase III, randomised, open-label, international clinical study of the…
In the battle against metastatic castrate-resistant prostate cancer, studies have demonstrated a high response rate…
Newly released data from the pivotal Phase III trial (TAGS) for trifluridine and tipiracil (TAS-102)…
I love a good plenary session at ASCO, and this year’s plenary session was one…
Darren Saunders, UNSW Findings from a major international clinical trial suggest a significant number of…
ASCO 2018 was another whirlwind of science, meetings, connections, and exhaustion. It is never possible…
In a small Phase II study of early-stage breast cancer patients with BRCA1/2 mutations, researchers…
